entertainment -WSS

entertainment

author：hotspot 2025-10-01 17:06:10 - browse：26

-- health tech coverage from STAT — Courtesy Xaia/Cedars-Sinai

Apple Vision Pro, the company’s most important new product in a decade, promises to envelop consumers in an immersive world of interactive content while employing clever technologies to make the device more usable and less alienating than virtual reality headsets that have come before it.

Marketing for Vision Pro has focused on the $3,499, 1.3-pound helmet’s potential for watching video, making work calls, viewing family photos, and other casual uses. But as with its other devices, Apple is eager to explore Vision Pro’s health potential as well. The company connected STAT with researchers from Cedars-Sinai and Boston Children’s Hospital who have developed applications that transform the headset into an AI powered chatbot that offers otherworldly therapy sessions or a virtual guide that can train nurses by simulating the chaos of a busy hospital.

VRx Health, founded by researchers from Cedars-Sinai in Los Angeles, is today launching Xaia, a mental health chatbot app that uses an artificial intelligence model to generate human-like responses to users’ statements. A therapeutic chatbot isn’t a new idea, but Xaia takes advantage of Vision Pro’s ability to convincingly blend digital content with an image of the world around users.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Amid AI frenzy, a top HHS official's quest to create safeguards

hotspot

explore

WSS

Biden report: The neurospychology of memory and aging

Readout Newsletter: CAR

Key House Republican on health care plans exit from Congress

How to save health care price transparency rules

Male and female sex labels in research insufficient, scientists say

What we’ve learned from the Aduhelm mess

entertainment

entertainment

focus

After affirmative action ruling, medical educators look to 'holistic review'

How many hemophilia patients actually want gene therapy?

How to save PrEP access — and even expand it

A disappointing year of Humira biosimilars

Supreme Court strikes down use of affirmative action

How digital tools helped lower hypertension in marginalized patients

Malaria cases in Florida and Texas: Here’s what you need to know

How to save health care price transparency rules

Tori Bowie and the unacceptable rates of Black maternal death

Medicare coverage of Wegovy, once blocked, now looks possible

entertainment

How digital tools helped lower hypertension in marginalized patients

Industry veterans launch new biotech VC with $310M

RaDonda Vaught links Vanderbilt hospital issues to patient death

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Change Healthcare outage fallout shows need for new oversight

Medicare Advantage proposed rates disappoint insurers

hotspot

explore

focus

leisure time